Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05308264
Title Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rigel Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Los Angeles RECRUITING Los Angeles California 90095 United States Details
University of California, Irvine RECRUITING Orange California 92868 United States Details
Mount Sinai Medical Center RECRUITING Miami Beach Florida 33140 United States Details
University of Miami RECRUITING Miami Florida 33136 United States Details
Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
Rutgers Cancer Institute of New Jersey WITHDRAWN New Brunswick New Jersey 09083 United States Details
Ichan School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
University of Texas, Southwestern RECRUITING Dallas Texas 75390 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field